Downregulated Expression of hsa_circ_0005556 in Gastric Cancer and Its Clinical Significance

Table 2

Relationship between hsa_circ_0005556 expression levels (ΔCq) and clinicopathological factors of patients with gastric cancer.

Characteristics	No. of cases (%)		value
Age (years)			0.331
<60	28 (29.5)
≥60	67 (70.5)
Gender			0.655
Male	25 (26.3)
Female	70 (73.7)
Diameter (cm)			0.061
<5	42 (44.2)
≥5	53 (55.8)
Differentiation			0.001
Well	8 (8.4)
Moderate	22 (23.2)
Poor	65 (68.4)
Lymphatic metastasis			0.039
N0	33 (34.7)
N1	19 (20.0)
N2	12 (12.6)
N3	31 (32.6)
Invasion			0.383
T1&TIS	17 (17.9)
T2	12 (12.6)
T3	8 (8.4)
T4	58 (61.0)
Distal metastasis			0.779
M0	87 (91.6)
M1	8 (8.4)
TNM stage			0.013
I&II	42 (44.2)
III&IV	53 (55.8)
CEA			0.415
Positive	12 (12.6)
Negative	83 (87.4)
CA19-9			0.617
Positive	42 (44.2)
Negative	53 (55.8)

SD: standard deviation; CEA: carcinoembryonic antigen; CA199: carbohydrate antigen 19-9; 5 patients are not included due to incomplete clinicopathological information.